References
- Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, Jin HJ, Tan KS, Wang DY, Yan Y. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Mil Med Res. 2020; 137(1):11. doi:https://doi.org/10.1186/s40779-020-00240-0.
- Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020; 395(10229):1054–62. doi:https://doi.org/10.1016/S0140-6736(20)30566-3.
- de Lucena TMC, da Silva Santos AF, de Lima BR, de Albuquerque Borborema ME, de Azevêdo Silva J. Mechanism of inflammatory response in associated comorbidities in COVID-19. Diabetes Metab Syndr. 2020; 14(4):597–600. doi:https://doi.org/10.1016/j.dsx.2020.05.025.
- Khoo AL, Chai L, Koenen H, Joosten I, Netea M, van der Ven A. Translating the role of vitamin D3 in infectious diseases. Crit Rev Microbiol. 2012; 38(2):122–35. doi:https://doi.org/10.3109/1040841X.2011.622716.
- Rajakumar K, de las Heras J, Chen TC, Lee S, Holick MF, Arslanian SA. Vitamin D status, adiposity, and lipids in black American and Caucasian children. J Clin Endocrinol Metab. 2011; 96(5):1560–7. doi:https://doi.org/10.1210/jc.2010-2388.
- Vyas N, Kurian SJ, Bagchi D, Manu MK, Saravu K, Unnikrishnan MK, Mukhopadhyay C, Rao M, Miraj SS. Vitamin D in prevention and treatment of COVID-19: current perspective and future prospects. J Am Coll Nutr. 2020; 1–14. doi:https://doi.org/10.1080/07315724.2020.
- Moulas AN, Vaiou M. Vitamin D fortification of foods and prospective health outcomes. J Biotechnol. 2018; 285:91–101. doi:https://doi.org/10.1016/j.jbiotec.2018.08.010.
- Aygun H. Vitamin D can prevent COVID-19 infection-induced multiple organ damage. Naunyn Schmiedebergs Arch Pharmacol. 2020; 393(7):1157–60. doi:https://doi.org/10.1007/s00210-020-01911-4.
- Jain SK, Parsanathan R. Can vitamin D and L-cysteine co-supplementation reduce 25(OH)-vitamin D deficiency and the mortality associated with COVID-19 in African Americans? J Am Coll Nutr. 2020;39(8):694–699. doi:https://doi.org/10.1080/07315724.2020.1789518.
- Kumar D, Gupta P, Banerjee D. Letter: does vitamin D have a potential role against COVID-19? Aliment Pharmacol Ther. 2020; 52(2):409–11. doi: https://doi.org/10.1111/apt.1580
- Yang P, Gu H, Zhao Z, Wang W, Cao B, Lai C, Yang X, Zhang L, Duan Y, Zhang S, et al. Angiotensin-converting enzyme 2 (ACE2) mediates influenza H7N9 virus-induced acute lung injury. Sci Rep. 2014; 4:7027. doi:https://doi.org/10.1038/srep07027.
- Mohammad S, Mishra A, Ashraf MZ. Emerging role of vitamin D and its associated molecules in pathways related to pathogenesis of thrombosis. Biomolecules. 2019; 9(11):649. doi:https://doi.org/10.3390/biom9110649.
- Aihara K, Azuma H, Akaike M, Ikeda Y, Yamashita M, Sudo T, Hayashi H, Yamada Y, Endoh F, Fujimura M, et al. Disruption of nuclear vitamin D receptor gene causes enhanced thrombogenicity in mice. J Biol Chem. 2004; 279(34):35798–802. doi:https://doi.org/10.1074/jbc.M404865200.
- Martineau AR, Jolliffe DA, Greenberg L, Aloia JF, Bergman P, Dubnov-Raz G, Esposito S, Ganmaa D, Ginde AA, Goodall EC, et al. Vitamin D supplementation to prevent acute respiratory infections: individual participant data meta-analysis. Health Technol Assess. 2019; 23(2):1–44. doi:https://doi.org/10.3310/hta23020.
- D’Avolio A, Avataneo V, Manca A, Cusato J, De Nicolò A, Lucchini R, Keller F, Cantù M. 25-Hydroxyvitamin D concentrations are lower in patients with positive PCR for SARS-CoV-2. Nutrients. 2020; 12(5):1359. doi:https://doi.org/10.3390/nu12051359.
- Merzon E, Tworowski D, Gorohovski A, Vinker S, Golan Cohen A, Green I, Frenkel-Morgenstern M. Low plasma 25(OH) vitamin D level is associated with increased risk of COVID-19 infection: an Israeli population-based study. FEBS J. 2020;287(17):3693–702. doi:https://doi.org/10.1111/febs.15495.
- Ilie PC, Stefanescu S, Smith L. The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality. Aging Clin Exp Res. 2020; 32(7):1195–8. doi:https://doi.org/10.1007/s40520-020-01570-8.
- Panarese A, Shahini E. Letter: Covid-19, and vitamin D. Aliment Pharmacol Ther. 2020;51(10):993–5. doi:https://doi.org/10.1111/apt.15752.
- Mikami T, Miyashita H, Yamada T. Risk factors for mortality in patients with COVID-19 in New York City [published online ahead of print, 2020 Jun 30]. J Gen Intern Med. 2020;1–10. doi:https://doi.org/10.1007/s11606-020-05983-z.
- AlQuaiz AM, Kazi A, Fouda M, Alyousefi N. Age and gender differences in the prevalence and correlates of vitamin D deficiency. Arch Osteoporos. 2018; 3(1):49. doi:https://doi.org/10.1007/s11657-018-0461-5.
- LaClair RE, Hellman RN, Karp SL, Kraus M, Ofner S, Li Q, Graves KL, Moe SM. Prevalence of calcidiol deficiency in CKD: a cross-sectional study across latitudes in the United States. Am J Kidney Dis. 2005; 45(6):1026–33. doi:https://doi.org/10.1053/j.ajkd.2005.02.029.
- Ishimura E, Nishizawa Y, Inaba M, Matsumoto N, Emoto M, Kawagishi T, Shoji S, Okuno S, Kim M, Miki T, et al. Serum levels of 1,25-dihydroxyvitamin D, 24,25-dihydroxyvitamin D, and 25-hydroxyvitamin D in nondialyzed patients with chronic renal failure. Kidney Int. 1999; 55(3):1019–27. doi:https://doi.org/10.1046/j.1523-1755.1999.0550031019.x.
- Abrishami A, Dalili N, Mohammadi Torbati P, Asgari R, Arab-Ahmadi M, Behnam B, Sanei-Taheri M. Possible association of vitamin D status with lung involvement and outcome in patients with COVID-19: a retrospective study. Eur J Nutr. 2020; 1–9. doi:https://doi.org/10.1007/s00394-020-02411-0.
- Ohaegbulam KC, Swalih M, Patel P, Smith MA, Perrin R. Vitamin D supplementation in COVID-19 patients: a clinical case series. Am J Ther. 2020;27(5):e485–e490. doi:https://doi.org/10.1097/MJT.0000000000001222.
- Rastogi A, Bhansali A, Khare N, Suri V, Yaddanapudi N, Sachdeva N, Puri GD, Malhotra P. Short term, high-dose vitamin D supplementation for COVID-19 disease: a randomised, placebo-controlled, study (SHADE study). Postgrad Med J. 2020. doi:https://doi.org/10.1136/postgradmedj-2020-139065.
- Annweiler G, Corvaisier M, Gautier J, Dubée V, Legrand E, Sacco G, Annweiler C. Vitamin D supplementation associated to better survival in hospitalized frail elderly COVID-19 patients: The GERIA-COVID quasi-experimental study. Nutrients 2020; 12(11):3377. doi:https://doi.org/10.3390/nu12113377.
- Han JE, Jones JL, Tangpricha V, Brown MA, Brown LAS, Hao L, Hebbar G, Lee MJ, Liu S, Ziegler TR, Martin GS. High dose vitamin D administration in ventilated intensive care unit patients: a pilot double blind randomized controlled trial. J Clin Transl Endocrinol. 2016; 4:59–65. doi:https://doi.org/10.1016/j.jcte.2016.04.004.
- Arvinte C, Singh M, Marik PE. Serum levels of vitamin C and vitamin D in a cohort of critically ill COVID-19 patients of a North American Community Hospital Intensive Care Unit in May 2020: a pilot study. Med Drug Discov. 2020; 8:100064. doi:https://doi.org/10.1016/j.medidd.2020.100064.
- Grimes DA, Schulz KF. False alarms and pseudo-epidemics: the limitations of observational epidemiology. Obstet Gynecol. 2012; 120(4):920–7. doi:https://doi.org/10.1097/AOG.0b013e31826af61a.
- Institute of Medicine, Food and Nutrition Board. Dietary reference intakes for calcium and vitamin D. Washington (DC): National Academy Press; 2010.
- Wang R, DeGruttola V, Lei Q, Mayer KH, Redline S, Hazra A, Mora S, Willett WC, Ganmaa D, Manson JE. The vitamin D for COVID-19 (VIVID) trial: a pragmatic cluster-randomized design. Contemp Clin Trials. 2021; 100 9:106176. doi:https://doi.org/10.1016/j.cct.2020.106176.